M. Monteiro Drummond Freitas (Maia, Portugal), D. Testelmans (Leuven, Belgium)
This session is built from abstracts published on the ERS Congress platform from 23 August, in a PowerPoint format with a pre-recorded audio narration. The live session is scheduled from September 5-7 and each presenter will have a 5-minutes live, slide show presentation followed at the end of the session by 30-minutes general discussion.
This session includes the Best Abstract for Assembly 4 - Sleep Disordered Breathing, entitled "Pitolisant long term effect in sleepy obstructive sleep apnea patients with CPAP”
Introduction
|  |
Pitolisant long term effect in sleepy obstructive sleep apnea patients with CPAP.
J. Pépin (Grenoble, France), O. Georgiev (Sofia, Bulgaria), R. Tiholov (Kozloduy, Bulgaria), V. Attali (Paris, France), J. Verbraecken (Edegem-Antwerp, Belgium), B. Buyse ( KU Leuven, Belgium), M. Partinen (Helsinki, Finland), I. Fietze (Berlin, Germany), G. Belev (Plovdiv, Bulgaria), D. Dokic (Macedoniav, North Macedonia), R. Tamisier (Grenoble, France), P. Lévy (Grenoble, France), C. CAUSSE (Paris, France), I. Lecomte (Paris, France), J. Lecomte (Paris, France), J. Schwartz (Paris, France), Y. Dauvilliers (Montpellier, France)
|   |
Acetazolamide effect on nocturnal oxygenation, breathing and sleep in healthy individuals older than 40 years. RCT.
M. Furian (Zurich, Switzerland), L. Graf (Zurich, Switzerland), B. Konstantinos (Zurich, Switzerland), M. Mademilov (Bishkek, Kyrgyzstan), A. Abdraeva (Bishkek, Kyrgyzstan), J. Buenzli (Zurich, Switzerland), S. Aydaralieva (Bishkek, Kyrgyzstan), U. Sheraliev (Bishkek, Kyrgyzstan), N. Marazhapov (Bishkek, Kyrgyzstan), T. Sooronbaev (Bishkek, Kyrgyzstan), S. Ulrich (Zurich, Switzerland), K. Bloch (Zurich, Switzerland)
| |
Safety and efficacy of sulthiame in moderate to severe obstructive sleep apnea: a randomized placebo-controlled parallel-group trial
J. Hedner (Göteborg, Sweden), K. Stenlof (Göteborg, Sweden), Z. Ding (Göteborg, Sweden), E. Hoff (Göteborg, Sweden), C. Hansen (Hamburg, Germany), K. Kuhn (Hamburg, Germany), P. Lennartz (Hamburg, Germany), L. Grote (Göteborg, Sweden)
| |
Moderate obstructive sleep apnea and cardiovascular outcomes in elder patients: a propensity score matched, multicentric study (CPAGE-MODE study)
J. Terán Tinedo (Madrid, Spain), I. Cano Pumarega (Madrid, Spain), T. Díaz Cambriles (Madrid, Spain), A. García Sánchez (Madrid, Spain), T. Gómez García (Madrid, Spain), P. Landete Rodríguez (Madrid, Spain), V. Lores Gutiérrez (Madrid, Spain), E. Mañas Baena (Madrid, Spain), M. Troncoso Acevedo (Madrid, Spain), E. Zamora García (Madrid, Spain), D. López-Padilla (Madrid, Spain)
| |
The effect of obstructive sleep apnoea on the retinal vascular reactivity: a randomised trial
C. Turnbull (Oxford (Oxfordshire), United Kingdom), R. Heitmar (Birmingham, United Kingdom), J. Stradling (Oxford (Oxfordshire), United Kingdom)
| |
Cheyne-Stokes respiration tracked by CPAP telemonitoring can detect serious cardiac events
A. Prigent (Rennes, France), C. Pellen (Rennes, France), J. Texereau (Paris, France), S. Bailly (Grenoble, France), N. Coquerel (Rennes, France), R. Gervais (Rennes, France), J. Liegaux (Rennes, France), R. Luraine (Rennes, France), J. Renaud (Rennes, France), S. Anne Laure (Rennes, France), J. Pépin (Grenoble, France)
| |
Rates of CPAP therapy termination in different obstructive sleep apnoea patient phenotypes: analysis of the French nationwide health claims database
J. Pepin (Grenoble, France), S. Bailly (Grenoble, France), P. Rinder (Paris, France), D. Adler (Geneva, Switzerland), D. Szeftel (Paris, France), A. Malhotra (San Diego, United States of America), P. Cistulli (Sydney, Australia), A. Benjafield (Sydney, Australia), F. Lavergne (Saint-Priest, France), A. Josseran (Saint-Priest, France), R. Tamisier (Grenoble, France), P. Hornus (Paris, France)
| |
Natural course of untreated obstructive sleep apnoea in patients with coronary artery disease in the RICCADSA trial
Y. Peker (Istanbul, Turkey), M. Saygin (Isparta, Turkey), E. Thunström (Gothenburg, Sweden), P. J Strollo Jr (Pittsburgh, United States of America)
| |
Prolonged symptoms and sleep quality after hospitalization for covid-19 in patients with obstructive sleep apnoea
I. Andreieva (Zaporizhzhia, Ukraine)
| |
Late Breaking Abstract - CPAP termination and all-cause mortality: a French nationwide database analysis
J. Pepin (Grenoble, France), S. Bailly (Grenoble, France), F. Lavergne (Saint-Priest, France), P. Rinder (Paris, France), D. Adler (Geneve, Switzerland), A. Benjafield (Sydney, Australia), A. Josseran (Saint-Priest, France), P. Sinel-Boucher (Paris, France), R. Tamisier (Grenoble, France), P. Cistulli (Sydney, Australia), A. Malhotra (San Diego, United States of America), P. Hornus (Paris, France)
| |